Imbed Biosciences Inc. is a privately held medical device company emerging as a leader in the development of advanced therapies for the treatment of burns, chronic ulcers, surgical wounds, and soft-tissue repair. The company has a portfolio of products in development based on its patented MicroLyte® Matrix technology that presents bioactive molecules on tissue surfaces to combat local pain and infections. This next generation, synthetic, antimicrobial matrix accelerates cell migration. Imbed Biosciences is registered with U.S. FDA as a medical device manufacturer and maintains an ISO 13485 certified Quality Management System. For more information, please visit www.imbedbio.com, www.MicrolyteMatrix.com, facebook.com/imbedbio, and follow @ImbedBio and @MicroLyteAgMtrx on twitter.